You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 2, 2026

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
Thomas J Graddis1, Catherine J McMahan, Jennifer Tamman
1Department of Immunology, University of Washington, Seattle, WA, USA.
Prostate cancer immunotherapy shows promise using prostatic acid phosphatase (PAP) as a target antigen. While PAP is found in other tissues, its expression is significantly higher in the prostate, supporting its use in cancer treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: